Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|March 11, 2026
Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran populationMei Wang, Byron Sigel, Lawrence Liu, et al.
The Oncologist|September 20, 2013
Influence of body mass index on survival in veterans with multiple myelomaTracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
Cardiovascular Therapeutics|August 5, 2016
Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivorsAnthony S Gunnell, Joseph Hung, Matthew W Knuiman, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
Knowledge, interest, and willingness of hematologists and oncologists to care for adults with vascular anomaliesBryan A Sisk, Anna M Kerr, Sally Cohen-Cutler, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
Hypertension (Dallas, Tex. : 1979)|November 4, 2022
Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry DataLachlan L Dalli, Muideen T Olaiya, Joosup Kim, et al.
Clinical Epidemiology|December 10, 2019
The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profileJudith M Katzenellenbogen, Daniela Bond-Smith, Rebecca J Seth, et al.
Neuroepidemiology|November 10, 2021
Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after StrokeMonique F Kilkenny, Muideen T Olaiya, Lachlan L Dalli, et al.
Pageof 28